<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="161470">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01930695</url>
  </required_header>
  <id_info>
    <org_study_id>CR013</org_study_id>
    <nct_id>NCT01930695</nct_id>
  </id_info>
  <brief_title>Post Market Clinical Follow-up of CRT-DX Therapy With Lumax 640/740 HF-T</brief_title>
  <acronym>Pre-CRAFT</acronym>
  <official_title>Post Market Clinical Follow-up of CRT-DX Therapy With Lumax 640/740 HF-T</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Biotronik SE &amp; Co. KG</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Clinical Trial Unit, University Hospital Basel, Switzerland</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Biotronik SE &amp; Co. KG</source>
  <oversight_info>
    <authority>Switzerland: Ethikkommission</authority>
    <authority>Germany: Ethics Commission</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study is designed to collect data of the performance and confirm the safety of the DX
      (Diagnostic eXtension) functionality in the Lumax 640/470 HF-T in patients with permanent
      atrial fibrillation and CRT-D indication according to current ESC guidelines. The DX
      functionality is a feature, which can be activated in the Lumax 640/740 HF-T when connected
      to the LinoxSMART S DX right ventricular lead. The combination of these devices enable
      atrial sensing via a sensing dipole in the ventricular lead and therefore reduces the number
      of implanted leads without sacrificing atrial information. Atrial pacing can not be provided
      but is not needed in patients with permanent atrial fibrillation.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2013</start_date>
  <completion_date type="Anticipated">September 2014</completion_date>
  <primary_completion_date type="Anticipated">July 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Case-Only, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Quality of IEGM recording</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>to assess if the IEGM Online recordings of the Lumax 640/740 HF-T with DX functionality provide adequate quality to classify the atrial rhythm</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Safety of the Lumax 640/740 HF-T with DX functionality based on the Serious Adverse Device Effects related to the DX functionality</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>to assess the safety of the Lumax 640/740 HF-T by the analysis of Serious Adverse Device Effects which are related to the DX functionality</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Safety of the Lumax 640/740 HF-T with DX functionality based on all, serious and non-serious, Adverse Device Effects related to DX functionality</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>to assess the safety of the Lumax 640/740 HF-T with DX functionality by the analysis of all (serious and non-serious) Adverse Device Effects which are related to the DX functionality</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of patients with maintenance of diagnosis of permanent AF</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>to investigate whether the diagnosis of permanent AF at enrollment is maintained after device implantation</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">25</enrollment>
  <condition>Atrial Fibrillation</condition>
  <condition>Heart Failure</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Heart Failure patients with CRT-D indication according to current ESC guidelines and
        permanent atrial fibrillation
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  CRT-D indication according to current ESC guidelines (NYHA III/IV; QRS≥120ms;
             LVEF≤35%; Expected survival ≥ 1 year; need for pacing because of slow ventricular
             rate or pacemaker dependency as a result of AV nodal ablation or ventricular rate
             ≤60bpm at rest and ≤90bpm on exercise)

          -  Permanent atrial fibrillation

          -  Patients planned to be implanted with BIOTRONIK Lumax 640/740 HF-T

          -  Patients planned to be implanted with BIOTRONIK LinoxSmart S DX right ventricular
             lead (or successors)

          -  Patient eligible for programming of DX functionality according to the physicians`
             decision

          -  Patient is willing and able to comply with the CIP and provided written informed
             consent

          -  Patient accepts Home Monitoring® concept and has sufficient GSM/GPRS coverage

        Exclusion Criteria:

          -  Patients with any contraindication to CRT-D therapy

          -  Patients listed for heart transplantation

          -  Life expectancy less than 12 months

          -  Pregnant or breast-feeding women

          -  Patients under the age of 18

          -  Patients with limited contractual capability

          -  Participation in any other clinical study
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christian Sticherling, Prof. Dr.</last_name>
    <role>Study Chair</role>
    <affiliation>Universitätsspital Basel, Petersgraben 4, 4031 Basel, Switzerland</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Silke Krüger, Dr.</last_name>
    <phone>+49 (0)30 68905 1335</phone>
    <email>silke.krueger@biotronik.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Herz- und Gefäßzentrum Bad Bevensen</name>
      <address>
        <city>Bad Bevensen</city>
        <zip>29549</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Dirk Müller, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Marien-Hospital Lünen</name>
      <address>
        <city>Lünen</city>
        <zip>44534</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Christian Perings, Prof. Dr. med.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UKGM Gießen Marburg</name>
      <address>
        <city>Marburg</city>
        <zip>35043</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Ulrich Lüsebrink, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Deutsches Herzzentrum München</name>
      <address>
        <city>München</city>
        <zip>80636</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Christof Kolb, PD. Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>DRK Mölln-Ratzeburg</name>
      <address>
        <city>Ratzeburg</city>
        <zip>23909</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Stefan Kuster, Dr. med.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Rostock</name>
      <address>
        <city>Rostock</city>
        <zip>18057</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Dietmar Bänsch, Prof. Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsspital Basel</name>
      <address>
        <city>Basel</city>
        <zip>4031</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christian Sticherling, Prof. Dr.</last_name>
    </contact>
    <investigator>
      <last_name>Christian Sticherling, Prof. Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>February 2014</verification_date>
  <lastchanged_date>February 20, 2014</lastchanged_date>
  <firstreceived_date>August 21, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>DX functionality</keyword>
  <keyword>Atrial fibrillation</keyword>
  <keyword>CRT-D indication</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Atrial Fibrillation</mesh_term>
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
